Form 4: DexCom EVP Sadie Stern Reports Acquisition of Restricted Stock Units

Sadie Stern, EVP and Chief Human Resources Officer of DexCom Inc., reports the acquisition of 21,711 restricted stock units.

Summary

• Sadie Stern, an executive at DexCom Inc., filed a Form 4 on March 11, 2024, reporting a transaction.
• On March 8, 2024, Stern acquired 21,711 shares of DexCom common stock in the form of restricted stock units.
• These restricted stock units were granted at a price of $0.0 and vest in three equal annual installments from the date of grant.
• Following the reported transaction, Stern beneficially owns 100,762 shares of DexCom common stock, including 53,995 unvested restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally neutral to slightly positive as it incentivizes management.

Positives

• The acquisition of restricted stock units aligns the executive's interests with the company's long-term performance.

Future Outlook

The restricted stock units vest over a three-year period, incentivizing continued service and performance.

Industry Context

Executive compensation through stock grants is a common practice in the technology and healthcare industries to align management's interests with shareholder value.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in publicly traded companies, particularly in high-growth sectors like medical technology.
• Companies like Medtronic and Abbott also utilize stock options and restricted stock units to incentivize their executives.

Key Dates